not tagged
Miltenyi Biomedicine
['leusm', 'dlbcl', 'lymphoma', 'lymsm']
#17icml reports current data from daly ii, investigating bispecific anti-cd20/anti-cd19 car t in 22 patients with r/r dlbcl post 2 lines of treatment. results have demonstrated a manageable safety profile with durable response (orr, 79%) #lymsm #leusm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm